Aceragen, Inc.
ACGNDelisted Aug 16, 2023- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000861838
Aceragen, Inc. was delisted on Aug 16, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 20 institutions reported holding it in 13F filings for Q2 2023, worth $269.5K in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Aceragen, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 3 | 0 | −3 |
| Shares | 1.35K | 0 | −1.35K (−100.0%) |
| Value | $0 | $0 | $0 |
New holders (0)
Institutions that held Aceragen, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
None.
Sold out (3)
Institutions that held Aceragen, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Caldwell Sutter Capital, Inc. | 294 | $0 |
| Hollencrest Capital Management | 999 | $0 |
| Parallel Advisors, LLC | 58 | $0 |